Corporate
-
Mergers & Acquisitions
Dr Reddy's acquisition includes research centre
Our Bureau
Hyderabad
,
Feb 17
THE big-ticket acquisition of Betapharm Arzneimittel, Germany by Dr Reddy's Laboratories for 480 million euros (around Rs 2,250 crore) also includes a not-for profit beta institute.
Founded in 1999, the beta institute focuses on applied health management. Its core services are focused on social-medical research, advanced training, consulting, project development, and information services.
For the research-driven Dr Reddy's Laboratories, the institute's strength to independently develop and prove innovative concepts in practice would be an added advantage.
According to a release from 3i, Europe's leading private equity and venture capital company, which sold Betapharm to Dr Reddy's, the beta institute works closely and evaluate these concepts with Universities.
Over the years, this approach has helped Betapharm bring several innovative solutions for today's healthcare system.
Related Stories:
Dr Reddy's buys German co Betapharm for Rs 2,250 cr — Biggest overseas acquisition by an Indian pharma co
More Stories on :
Mergers & Acquisitions |
Pharmaceuticals |
Dr. Reddy's Laboratories Ltd
Article
E-Mail
::
Comment
::
Syndication
::
Printer Friendly Page
|
